Medical Research
(H200)
990 on File
RESEARCH FUND FOR CYSTIC FIBROSIS INC
Financial strength (30%)
59/100
Reliability (20%)
55/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$79K
Total Revenue
$1.1M
Total Expenses
$777K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
99.7%
Fundraising Efficiency
N/A
Operating Reserve
8.51x
Liability-to-Asset
0.0%
Revenue Diversification
97.8%
Executive Compensation
$0
Compared with Peers
FY 2024
Compared with 332 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
99.7% | 83.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
8.5 mo | 12.8 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 10.1% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
97.8% | 90.7% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-6.7% | 12.5% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
47.4% | 11.1% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-1292.6% | 2.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $79K | $1.1M | $777K | 99.7% | — |
| 2023 | $84K | $743K | $1.3M | 98.8% | — |
| 2022 | $84K | $391K | $1.6M | 92.9% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.